American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The TQCC of American Journal of Clinical Oncology-Cancer Clinical Trials is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy61
Death From Infection Among Patients Living With Cancer40
Cardiac Angiosarcomas24
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy23
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma17
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors16
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients14
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia13
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers13
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?13
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma12
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer11
Third-line Treatment for Metastatic Triple-negative Breast Cancer11
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer10
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer10
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer10
Efficacy and Safety of Camrelizumab Plus Apatinib for Esophageal Squamous Cell Carcinoma10
Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas10
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy10
Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction9
Hypofractionated Radiation Therapy9
Prospective Validation of An Inpatient Metastatic Spine Neoplasm Score To Assess the Optimal Radiation Therapy Intervention Modality9
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer9
Beyond the Clinic9
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus9
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer8
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 20158
Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy8
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites8
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy7
SBRT vs. Y907
Early Cancer Screening Impressions of African-American Breast Cancer Patients Enrolled on the Navigator-Assisted Hypofractionation (NAVAH) Trial7
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy7
A Meta-analysis on Effects of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia7
ACR–ARS Practice Parameter for Radiation Oncology7
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma7
Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas7
ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride7
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases7
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer7
Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial6
Quantification of Postdiagnosis Cancer Patient Navigation6
Treatment of Cancer Pain6
Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy6
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas6
Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer6
Crossover in Adjuvant Trastuzumab Trials6
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies6
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients6
Overactive Bladder Symptoms in Cancer Patients Undergoing Chemotherapy6
Sacituzumab Govitecan-hziy in Breast Cancer5
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer5
Incidence and Risk of Second Primary Malignancies After Treatment for Papillary Thyroid Cancer5
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures5
Mortality Patterns of Esophageal Cancer in the United States5
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy5
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma5
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage5
Why Basic Science Education Matters in Radiation Oncology5
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer5
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer5
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors5
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy5
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer5
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer5
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease5
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status5
The Best Interest5
The microRNA-34 Family and Its Functional Role in Lung Cancer4
Metaplastic Breast Carcinoma4
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer4
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment4
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model4
Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma4
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer4
Laparoscopic Versus Abdominal Radical Hysterectomy4
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients4
Geospatial Mapping of Head and Neck Cancer Research4
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors4
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases4
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer4
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?4
Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients4
The Balance and Imbalance of Microbial Communities4
Long COVID in Cancer4
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma4
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings4
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer4
Long-Term Outcomes After Abdominal Radiation for Wilms Tumor4
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy3
Proceedings of the American Radium Society® 104th Annual Meeting3
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer3
Five Fraction External Beam Partial Breast Irradiation3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation3
Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer–A Systematic Review and Meta-Analysis3
Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists3
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy3
Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer3
Prevalence and Development of Cachexia Before and After Diagnosis of Non–small Cell Lung Cancer3
Beyond Treatment3
Practice Patterns of Surveillance in Sentinel Lymph Node-Positive Malignant Melanoma3
How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery3
Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer3
Social Determinants of Health in Oncology3
Executive Summary of the American Radium Society Appropriate Use Criteria3
Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Mu3
Advancements in Diagnosis and Multimodal Treatment Strategies for Retroperitoneal Tumors3
The Biology and Systemic Treatments Influence Survival in Advanced Gastrointestinal Cancers While the Controlled Trial of Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Found That Surgical Re3
Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma3
A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials3
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients3
H-Index and Promotion in Academic Radiation Oncology3
Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials3
Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients3
Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography3
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy: Erratum3
0.14818406105042